CRT 2017 : RENAL DENERVATION & HYPERTENSION THERAPIES - New Data and Clinical Trial Design Update

Conference

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$16.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Overview

RENAL DENERVATION & HYPERTENSION THERAPIES - New Data and Clinical Trial Design Update

Featuring

  • Felix Mahfoud
  • Thomas Luescher
  • Arie Steinvil
  • Vasilios Papademetriou
  • Michael Weber

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$16.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Moment Components

Long-Term Outcome of OUS Renal Denervation Trials - Felix Mahfoud
Should SPRINT Change Your Practice - Thomas Luescher
Update on SPYRAL HTN: Global Studies Update - Felix Mahfoud
Critical Appraisal of the Current Ongoing Study Designs - Thomas Luescher
SYMPLICITY 3 Lessons Learned from Screening - Arie Steinvil
Update on the RADIANCE-HTN Study - Felix Mahfoud
Enlighten Renal Denervation Program Update - Vasilios Papademetriou
Update on REINFORCE Study - Michael Weber

Target Audience

Learning Objectives

Related Moments

CRT 2017 : FDA Town Hall - Medtech in Transition: Where are we now and what lies ahead?
Conference
Long-term Outcomes of Ventricular Tachycardia Ablation in Different Types of Structural Heart Disease
Journal
Article on Long-term Outcomes of Ventricular Tachycardia Ablation in Different Types of Structural Heart Disease
Pulmonary Oedema—Therapeutic Targets
Journal
Article on Pulmonary Oedema—Therapeutic Targets
Loading Simple Education